Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Windtree Therapeutics

Recent news which mentions Windtree Therapeutics

Windtree Therapeutics – This Biotech Inks License Deal For Lead Candidate
Tickers WINT
Tags Interview Biotech WINT
From Benzinga
Windtree Therapeutics (NASDAQ: WINT) Eliminates $15 Million Contingent Liability To Deerfield Management Company
Tickers NEWS WINT
Tags Benzinga Penny Stocks Market News
From Benzinga
Up To $138 Million in Milestones, Up To Low Double Digit Royalties: Windtree Announces Agreement To Develop And Commercialize Drug Candidates In Greater China
Tickers NEWS WINT
Tags General Partner Content Windtree Therapeutics
From Benzinga
Windtree Therapeutics Announces Reduction In Arrhythmias In A New Study With Istaroxime And A Pure SERCA2a Activator
Tickers NEWS WINT
Tags Market News Penny Stocks Benzinga
From Benzinga
Istaroxime Update: Start Of Patient Dosing In Early Cardiogenic Shock SEISMiC Extension Study In Preparation For Phase 3 Readiness, Topline Data Expected mid-2024
Tickers WINT
Tags Partner Content Windtree Therapeutics WINT
From Benzinga
Windtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators In A Multi-Billion Dollar Market
Tickers WINT
Tags Market News Penny Stocks Benzinga
From Benzinga
How Windtree Therapeutics (NASDAQ: WINT) Is Developing A Multi-Asset Franchise Of Its Novel SERCA2a Activators
Tickers WINT
Tags Market News Benzinga Penny Stocks
From Benzinga
Windtree Therapeutics' (NASDAQ: WINT) Upcoming Istaroxime Development Milestones And Next Generation Drug Candidates Could Produce New Fast Follow-On Line Of Drugs For Heart Failure
Tickers WINT
Tags General Partner Content WINT
From Benzinga
The Acute Hospital Care Market Is Worth Over $3 Trillion, And Windtree Therapeutics Brings A First-In-Class Drug To An Active Segment Of This Market
Tickers AZN BMY MLYS NVS
Tags Market News MLYS Benzinga
From Benzinga
Windtree Therapeutics – This Biotech Is Developing Drugs For Patients In Crisis
Tickers WINT
Tags Penny Stocks Benzinga Market News
From Benzinga
Medical Management Of Deadly Urgent Cardiogenic Shock Largely Remains A Challenge – Windtree Therapeutics (NASDAQ: WINT) Is Helping Change That
Tickers BMY NVS WINT
Tags Market News Penny Stocks Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.